Drug News

Medindia's Press Release’ section provides the latest press release on Drug from across the world for the global audience. This page links to 12880 Drug press releases.

Hopeful of Reduced Regulation, Biotech Stocks Stay the Course with Advanced Drug Developments

PALM BEACH, Florida , January 19, 2017 /PRNewswire/ -- While various reports indicate the incoming Trump administration appears serious about reducing the FDA's regulatory strictness as a way to boost advancements and innovation in the ...


Symbiomix Therapeutics Submits New Drug Application to US FDA for Solosec™ for the Treatment of BV

NEWARK, N.J. , Jan. 19, 2017 /PRNewswire/ -- Symbiomix, a biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections, today announced submission of a new drug application (NDA) for Solosec™ ...

Milner Therapeutics Institute Announces New Partnership with US Pharmaceutical Company Pfizer

CAMBRIDGE, England , January 19, 2017 /PRNewswire/ -- Pfizer joins Astex, AstraZeneca, GlaxoSmithKline, Shionogi, MedImmune and Otsuka in the Milner Therapeutics Consortium   Major research investment to work with academic ...

Two More Leading Pharmaceutical Companies to Rely on psiXchange for Process Automation

KAISERSLAUTERN, Germany , January 19, 2017 /PRNewswire/ -- pharmasol, a global leader in software development and product implementation for the life sciences industry, today announced two new pharmaceutical customers for its flagship ...

Can-Fite BioPharma Announces $5 Million Registered Direct Offering

PETACH TIKVA, Israel , Jan. 19, 2017 /PRNewswire/ --  Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI) , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory ...

U.S. FDA Acknowledges Receipt of Shire's New Drug Application for SHP465 for ADHD

LEXINGTON, Massachusetts , January 19, 2017 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the Class 2 resubmission of a New Drug Application (NDA) ...

Ethypharm Acquires Martindale Pharma in the UK

SAINT-CLOUD, France and WOOBURN GREEN, England , January 19, 2017 /PRNewswire/ -- Ethypharm is pleased to announce today that it has signed a definitive agreement to acquire Martindale Pharma. Martindale Pharma is a leading UK-based ...

Vial Adaptors for Reconstitution Drug Market to be Worth US$1.3 Billion by 2024: Reduced Risk of Needlestick Injuries Ups Demand, Notes TMR

ALBANY, New York , January 19, 2017 /PRNewswire/ -- The  Global Vial Adapt o r for Reconstitution Drug Market is fairly consolidated as top four players hold a leading share in the global market. A report by Transparency Market ...

Hepatitis C-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

LONDON , Jan. 18, 2017 /PRNewswire/ -- DelveInsight's Report, "Hepatitis C-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs ...

Drug Delivery Technology Market by Route of Administration, Patient Care Setting - Global Forecast to 2021

NEW YORK , Jan. 18, 2017 /PRNewswire/ -- The drug delivery technology market is projected to reach USD 1,669.40 billion by 2021 from USD 1,179.20 billion in 2016, at a CAGR of 7.2% during the forecast period.Increasing prevalence of ...

Drug News »

Diabetes and Obesity Market of GLP-1 Drugs Will Be $125 Billion By 2033!

Diabetes and Obesity Market of GLP-1 Drugs Will Be $125 Billion By 2033!

The type 2 diabetes and obesity market for GLP-1R agonists is expected to reach $125 billion in 7 major markets by 2033. This estimation has been projected by GlobalData, a leading data and analytics company ( ). Glucagon-like ...

Blood Pressure Drugs Double Bone-Fracture Risk

Blood Pressure Drugs Double Bone-Fracture Risk

Blood pressure medications significantly elevate the risk of life-threatening bone fractures, as per research by Rutgers Health published in JAMA Internal Medicine. The...

Generic Dexamethasone Tablets: USFDA Approval to Zydus for Arthritis

Generic Dexamethasone Tablets: USFDA Approval to Zydus for Arthritis

Zydus Lifesciences, an Indian pharmaceutical company, revealed on Saturday that it has obtained the final approval from the US Food and Drug Administration (USFDA) to distribute a generic drug for arthritis and various other ...

Safety of Rotavirus Vaccinations in NICU Babies

Safety of Rotavirus Vaccinations in NICU Babies

Providing rotavirus vaccine to infants in neonatal intensive care units (NICUs) is safe and does not lead to disease outbreaks ( ). Rotaviruses are majorly responsible for diarrheal disease among infants and young children. The vaccine, which ...

Dapagliflozin: A Potential Aid in Acute Heart Failure

Dapagliflozin: A Potential Aid in Acute Heart Failure

Dapagliflozin, a medication prescribed for managing Type 2 diabetes , has demonstrated additional benefits in heart failure conditions. This drug lowers the likelihood of hospitalization due to heart failure and mortality in ...

More Drug News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.